These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1364498)

  • 1. [Immunoenzymatic method for determining thyroglobulin levels in human blood serum].
    Lewartowska A; Gardas A
    Endokrynol Pol; 1991; 42(3):481-9. PubMed ID: 1364498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
    Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
    Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer.
    Cho YY; Chun S; Lee SY; Chung JH; Park HD; Kim SW
    Ann Lab Med; 2016 Sep; 36(5):413-9. PubMed ID: 27374705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of two methods to assay thyroglobulin serum concentrations in patients with differentiated thyroid carcinomas.
    Ferrari L; Seregni E; Aliberti G; Martinetti A; Pallotti F; Villano C; Lucignani G; Bombardieri E
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):237-42. PubMed ID: 15499298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-sensitivity enzyme-linked immunosorbent assay for serum thyroglobulin.
    Wunderlich G; Zöphel K; Crook L; Smith S; Smith BR; Franke WG
    Thyroid; 2001 Sep; 11(9):819-24. PubMed ID: 11575850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance between thyroglobulin antibody assays.
    Taylor KP; Parkington D; Bradbury S; Simpson HL; Jefferies SJ; Halsall DJ
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):367-9. PubMed ID: 21502198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity human thyroglobulin (hTG) immunoradiometric assay in the follow-up of patients with differentiated thyroid cancer.
    Giovanella L; Ceriani L
    Clin Chem Lab Med; 2002 May; 40(5):480-4. PubMed ID: 12113292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients.
    Duren M; Siperstein AE; Shen W; Duh QY; Morita E; Clark OH
    Surgery; 1999 Jul; 126(1):13-9. PubMed ID: 10418587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum thyroglobulin measurements with a high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma?
    Zöphel K; Wunderlich G; Smith BR
    Thyroid; 2003 Sep; 13(9):861-5. PubMed ID: 14588100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer.
    Spencer C; Fatemi S; Singer P; Nicoloff J; Lopresti J
    Thyroid; 2010 Jun; 20(6):587-95. PubMed ID: 20470203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of efficacy of various methods of thyroglobulin measurements in differentiated thyroid cancer].
    Czernik E; Deja R; Gubała E; Kukulska A; Turska M; Dabrowska-Czuba E; Bartnikowa W; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():339-48. PubMed ID: 12182046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
    Weightman DR; Mallick UK; Fenwick JD; Perros P
    Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer.
    Spencer CA; Lopresti JS
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):223-33. PubMed ID: 18268520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood.
    Ringel MD; Ladenson PW; Levine MA
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4435-42. PubMed ID: 9851791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New-generation thyroglobulin assay: performance and implications for follow-up of differentiated thyroid carcinoma.
    Roger C; Chikh K; Raverot V; Claustrat F; Borson-Chazot F; Bournaud-Salinas C; Charrié A
    Ann Endocrinol (Paris); 2014 Sep; 75(4):227-31. PubMed ID: 25168109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of a new IRMA for determining thyroglobulin].
    Heinze HG; Rall M
    Nuklearmedizin; 1992 Oct; 31(5):172-7. PubMed ID: 1465354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inappropriately undetectable thyroglobulin after exclusion of interference from thyroglobulin antibodies].
    Munier P; Courtier F; Barrial K; Chikh K; Claustrat F; Le Bricon T; Bronner J; Sanabria E
    Ann Biol Clin (Paris); 2011; 69(6):721-5. PubMed ID: 22123574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Continously increasing sensitivity in thyroid cancer aftercare in the course of three generations of thyroglobulin IMAs].
    Görges R; Brandt-Mainz K; Freudenberg L; Frilling A; Grimm W; Bockisch A
    Nuklearmedizin; 2003 Aug; 42(4):157-66. PubMed ID: 12937694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients.
    Elisei R; Vivaldi A; Agate L; Molinaro E; Nencetti C; Grasso L; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):33-9. PubMed ID: 14715824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.